EUVIMEDEUVIMED entdecken
Crossref

Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre ® System Initiation in Some People With Type 2 Diabetes on Insulin-Secretagogue Oral Drug Therapy Without Insulin in France

Jean-Pierre Riveline, Fleur Levrat-Guillen, Bruno Detournay iD, Eric Vicaut, Gérard De Pouvourville, Corinne Emery, Bruno Guerci

Diabetes Technology & Therapeutics · 2024

DOI: 10.1089/dia.2024.0171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Technology & Therapeutics, 2024. Verfasst von Jean-Pierre Riveline und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Diabetology, Lariboisière Hospital, Paris, France. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemic Agents, Hospitalization, Insulin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Glycemic management in people with type 2 diabetes mellitus (T2DM) on insulin-secretagogue regimens without insulin is of importance, as this group still represents a significant proportion of patients. Risks for acute diabetes events (ADEs), including diabetic ketoacidosis (DKA) or hypoglycemia, using insulin-secretagogue drugs are well established. Few studies have suggested that continuous glucose monitoring (CGM) could be useful for monitoring glucose dynamics associated with the use of such therapies. To document this point an exploratory analysis was conducted in a group of individuals with noninsulin treated T2DM in France who are managed with oral insulin-secretagogues and initiating the FreeStyle Libre ® system (FSL).

Methods

A retrospective study of the French national SNDS reimbursement claims database (≈66 million French people) was conducted to identify people with T2DM on oral insulin-secretagogues and receiving a first reimbursement of FSL between August 1, 2017 and December 31, 2018. The analysis included data for the 12 months before and up to 24 months after FSL initiation. Hospitalizations for diabetes-related acute events were identified using ICD-10 codes as main or related diagnosis, for: hypoglycemic events; DKA events; comas; and hyperglycemia-related admissions.

Results

A total of 1272 people with T2DM on insulin-secretagogues without insulin initiated FSL during the selection period. Of these, 7.15% had at least one hospitalization for any ADE in the year before FSL initiation, compared with 2.52% at 12 months and 2.83% at 24 months following FSL initiation. Reductions in ADEs were driven by −73% fewer admissions for ADEs related to diabetic ketoacidosis (DKA) or other hyperglycemia-related events. These patterns of reduced ADEs persisted after 2 years.

Conclusions

This study suggests the value of the FSL system in reducing ADEs in some people with T2DM in France being treated with insulin-secretagogues without insulin. Characteristics of these patients remain to be documented.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Hypoglycemic AgentsHospitalizationInsulinHumansFranceRetrospective StudiesMaleFemaleMiddle AgedAgedDiabetic KetoacidosisBlood Glucose Self-MonitoringAdministration, OralBlood GlucoseAdultHypoglycemia

Stichwörter der Autor:innen

FreeStyle Libreacute diabetes eventscontinuous glucose monitoringflash glucose monitoringinsulin-secretagoguesnoninsulin therapytype 2 diabetes

Substanzen

Hypoglycemic AgentsInsulinBlood Glucose

Autor:innen und Institutionen

  • Department of Endocrinology and Diabetology, Lariboisière Hospital, Paris, France.
  • INSERM U1151, CNRS UMR 8253, Institut Necker Enfants Malades, IMMEDIAB Laboratory, Paris, France.
  • Abbott Laboratories, Maidenhead, UK.
  • CEMKA, Bourg-la-Reine, France.
  • Clinical Research Unit, Fernand Vidal Hospital, Paris, France.
  • Department of Economics, ESSEC Business School, Cergy-Pontoise, France.

ORCID-Profile: Bruno Detournay

Zitieren

APA

Riveline, J. P., Levrat-Guillen, F., Detournay, B., Vicaut, E., De Pouvourville, G., Emery, C., & Guerci, B. (2024). Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre ® System Initiation in Some People With Type 2 Diabetes on Insulin-Secretagogue Oral Drug Therapy Without Insulin in France. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2024.0171

Vancouver

Riveline JP, Levrat-Guillen F, Detournay B, Vicaut E, De Pouvourville G, Emery C, et al. Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre ® System Initiation in Some People With Type 2 Diabetes on Insulin-Secretagogue Oral Drug Therapy Without Insulin in France. Diabetes Technology & Therapeutics. 2024. doi:10.1089/dia.2024.0171

BibTeX
@article{Riveline2024,
  author = {Riveline, Jean-Pierre and Levrat-Guillen, Fleur and Detournay, Bruno and Vicaut, Eric and De Pouvourville, Gérard and Emery, Corinne and Guerci, Bruno},
  title = {Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre ® System Initiation in Some People With Type 2 Diabetes on Insulin-Secretagogue Oral Drug Therapy Without Insulin in France},
  journal = {Diabetes Technology & Therapeutics},
  year = {2024},
  doi = {10.1089/dia.2024.0171}
}
Kostenlos starten →